Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 3250 of 3546 entries
View as:

Study With GW274150 In Patients With Mild Asthma

Phase: N/A Priority: Normal
NCT ID: NCT00273013 Org: User:
Start: 11/15/04 End: 10/28/05 Due: 10/28/06

A 12-Month Study Comparing Fluticasone Propionate/Salmeterol (ADVAIR) DISKUS Combination Product 250/50mcg Twice Daily To Fluticasone Propionate (FLOVENT) DISKUS 250 mcg Twice Daily In Symptomatic Patients With Asthma

Phase: N/A Priority: Normal
NCT ID: NCT00452348 Org: User:
Start: 05/31/07 End: 04/30/09 Due: 04/30/10

In-patient Study in Patients With Type 2 Diabetes Mellitus

Phase: N/A Priority: Normal
NCT ID: NCT00259896 Org: User:
Start: 10/31/05 End: - Due: -

Organized Program To Initiate Lifesaving Treatment In Hospitalized Patients With Heart Failure (OPTIMIZE-HF)

Phase: N/A Priority: Normal
NCT ID: NCT00344513 Org: User:
Start: 12/16/02 End: 06/30/05 Due: 06/30/06

To Characterize the Performance of the Nasal Dilator Strip in Lowering Nasal Resistance During Sleep, Promoting Nasal Route Breathing and Reducing the Signs and Symptoms of Sleep Disordered Breathing in a Group of Chronic Nocturnal Nasal Congestion Sufferers Who Report Trouble With Their Sleep.

Phase: N/A Priority: Normal
NCT ID: NCT03105297 Org: User:
Start: 09/25/09 End: 08/10/10 Due: 08/10/11

Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Monovalent Pandemic H5N1 Vaccine in Adults

Phase: N/A Priority: Normal
NCT ID: NCT01416571 Org: User:
Start: 08/12/11 End: 09/28/12 Due: 09/28/13

Efficacy and Safety of GSK3196165 Versus Placebo and Tofacitinib in Participants With Moderately to Severely Active Rheumatoid Arthritis Who Have an Inadequate Response to Conventional Synthetic (cs)/Biologic (b) Disease Modifying Anti-rheumatic Drugs (DMARDs)

Phase: N/A Priority: Normal
NCT ID: NCT03970837 Org: User:
Start: 06/05/19 End: 01/18/23 Due: 01/18/24

Safety, Tolerability, Pharmacokinetic and Microbiological Investigation of GSK3882347 in Female Participants With Urinary Tract Infections

Phase: N/A Priority: Normal
NCT ID: NCT05138822 Org: User:
Start: 05/18/22 End: 12/03/24 Due: 12/03/25

A Study on the Immune Response and Safety of Various Potencies of an Investigational Chickenpox Vaccine Compared With a Marketed Chickenpox Vaccine, Given to Healthy Children 12 to 15 Months of Age

Phase: N/A Priority: Normal
NCT ID: NCT05084508 Org: User:
Start: 02/03/22 End: 06/13/24 Due: 06/13/25

Pazopanib (VOTRIENT) Plus Paclitaxel (TAXOL), Pazopanib Plus Paclitaxel (TAXOL) Plus Carboplatin (PARAPLATIN), and Pazopanib Plus Paclitaxel (TAXOL) Plus Lapatinib (TYKERB)

Phase: N/A Priority: Normal
NCT ID: NCT00388076 Org: User:
Start: 04/28/06 End: 07/21/09 Due: 07/21/10

A Study in Children With Different Formulations of GSK Biologicals' 11 Valent Pneumococcal Conjugate Vaccine

Phase: N/A Priority: Normal
NCT ID: NCT00169481 Org: User:
Start: 10/31/04 End: 05/31/05 Due: 05/31/06

Dutasteride (GI198745) In Benign Prostatic Hyperplasia Subjects

Phase: N/A Priority: Normal
NCT ID: NCT00368979 Org: User:
Start: 02/17/06 End: 12/06/07 Due: 12/06/08

Pediatric Lupus Trial of Belimumab Plus Background Standard Therapy

Phase: N/A Priority: Normal
NCT ID: NCT01649765 Org: User:
Start: 09/07/12 End: 04/05/28 Due: 04/05/29

Study To Investigate If Repeat Doses Of GSK598809 Are Safe And Well Tolerated And To Evaluate Blood Levels Of GSK598809

Phase: N/A Priority: Normal
NCT ID: NCT00437632 Org: User:
Start: 03/01/07 End: 08/22/08 Due: 08/22/09

To Assess Safety, Reactogenicity & Immunogenicity of 2 Doses of GSK's Oral Human Rotavirus Vaccine in Pre-Term Infants

Phase: N/A Priority: Normal
NCT ID: NCT00420745 Org: User:
Start: 01/25/07 End: 03/25/08 Due: 03/25/09

Repeat Dose Study of GSK3772847 in Participants With Moderate to Severe Asthma With Allergic Fungal Airway Disease (AFAD)

Phase: N/A Priority: Normal
NCT ID: NCT03393806 Org: User:
Start: 04/18/18 End: 01/06/20 Due: 01/06/21

Meta-analysis - Eltrombopag

Phase: N/A Priority: Normal
NCT ID: NCT01235988 Org: User:
Start: 08/31/09 End: 10/31/09 Due: 10/31/10

A Single Dose Of Compound SB-681323 Compared To Prednisolone On A Protein That Is an Indicator For Rheumatoid Arthritis

Phase: N/A Priority: Normal
NCT ID: NCT00134693 Org: User:
Start: 06/21/05 End: 08/03/06 Due: 08/03/07

Effects Of Prednisolone On Rheumatoid Arthritis Patients

Phase: N/A Priority: Normal
NCT ID: NCT00330889 Org: User:
Start: 02/29/04 End: 12/31/06 Due: 12/31/07

A Phase 1, First Time in Human (FTIH) Study to Evaluate GSK3352589, a REarranged During Transfection (RET) Growth Factor Receptor Tyrosine Kinase Inhibitor, in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT03154086 Org: User:
Start: 05/17/17 End: 03/05/18 Due: 03/05/19

First-time-in-human (FTIH) Study of GSK3145095 Alone and in Combination With Other Anticancer Agents in Adults With Advanced Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT03681951 Org: User:
Start: 11/16/18 End: 08/13/19 Due: 08/13/20

Evaluate the Efficacy and Safety of GSK573719 Delivered Via a Novel Dry Powder Inhaler in Subjects With COPD

Phase: N/A Priority: Normal
NCT ID: NCT01387230 Org: User:
Start: 07/01/11 End: 02/13/12 Due: 02/13/13

A Study for Evaluation of Immunogenicity and Reactogenicity of Fluarix™ / Influsplit SSW® 2008/2009 in Adults

Phase: N/A Priority: Normal
NCT ID: NCT00706563 Org: User:
Start: 07/07/08 End: 07/30/08 Due: 07/30/09

Insulin Resistance as Primary Pathogenesis in Newly Diagnosed, Drug naïve Type 2 Diabetes Patients in Korea

Phase: N/A Priority: Normal
NCT ID: NCT01154244 Org: User:
Start: 09/30/09 End: 07/31/10 Due: 07/31/11

An Open Study to Evaluate Whether Pack Size Affects Compliance of Metformin Treatment in Subjects With Type II Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT01817777 Org: User:
Start: 05/31/13 End: 02/28/14 Due: 02/28/15